STAROPOLI, Nicoletta
 Distribuzione geografica
Continente #
NA - Nord America 464
AS - Asia 447
EU - Europa 358
SA - Sud America 166
AF - Africa 9
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.447
Nazione #
US - Stati Uniti d'America 440
SG - Singapore 217
IT - Italia 181
BR - Brasile 136
CN - Cina 81
DE - Germania 70
VN - Vietnam 60
IN - India 44
GB - Regno Unito 25
FI - Finlandia 20
CA - Canada 17
SE - Svezia 14
HK - Hong Kong 13
RU - Federazione Russa 13
NL - Olanda 10
AR - Argentina 9
EC - Ecuador 7
ID - Indonesia 7
TR - Turchia 7
MX - Messico 6
BD - Bangladesh 5
ES - Italia 5
CL - Cile 4
CO - Colombia 4
CZ - Repubblica Ceca 4
JP - Giappone 4
PK - Pakistan 4
VE - Venezuela 4
ZA - Sudafrica 4
AT - Austria 3
FR - Francia 3
PL - Polonia 3
EG - Egitto 2
JO - Giordania 2
PY - Paraguay 2
UA - Ucraina 2
AU - Australia 1
BY - Bielorussia 1
CH - Svizzera 1
DZ - Algeria 1
EU - Europa 1
IQ - Iraq 1
KI - Kiribati 1
LB - Libano 1
MA - Marocco 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TL - Timor Orientale 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 1.447
Città #
Singapore 86
Dallas 71
Munich 59
Chandler 46
Bengaluru 36
Hefei 35
Ashburn 30
Santa Clara 26
Chicago 24
Ho Chi Minh City 20
Milan 19
Turku 19
London 18
Hanoi 16
Hong Kong 13
Beijing 12
Carbonia 12
Catanzaro 12
São Paulo 12
Lawrence 11
Naples 11
Princeton 11
Rome 11
Wilmington 9
Los Angeles 8
New York 8
The Dalles 8
Boardman 7
Ottawa 7
Parma 7
Montreal 5
Amsterdam 4
Brasília 4
Charlotte 4
Da Nang 4
Ercolano 4
Melito di Porto Salvo 4
Olomouc 4
Porto Alegre 4
Reggio Calabria 4
Tokyo 4
Afragola 3
Ankara 3
Atlanta 3
Belo Horizonte 3
Biên Hòa 3
Campina Grande 3
Carapicuíba 3
Guayaquil 3
Haiphong 3
Manaus 3
Moscow 3
Nuremberg 3
Redmond 3
Rio de Janeiro 3
Santo Stefano di Rogliano 3
Warsaw 3
Amman 2
Augusta 2
Benevento 2
Bisignano 2
Bismarck 2
Boston 2
Brooklyn 2
Buffalo 2
Campinas 2
Canoas 2
Catania 2
Cavallino 2
Chennai 2
Columbus 2
Curitiba 2
Des Moines 2
Esslingen am Neckar 2
Florianópolis 2
Gatchina 2
Guarulhos 2
Jiaxing 2
Johannesburg 2
Lahore 2
Manchester 2
Marcianise 2
Medellín 2
Mountain View 2
Niterói 2
Osasco 2
Phoenix 2
Pittsburgh 2
Posadas 2
Quito 2
Recife 2
Romainville 2
Rosario 2
San Nicola Manfredi 2
Seattle 2
Serra San Bruno 2
Shenzhen 2
Spezzano della Sila 2
St Petersburg 2
Stockholm 2
Totale 843
Nome #
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 94
Distinctive germline expression of class i human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade 76
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer 66
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 60
Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients 57
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. (CO-FIRST AUTHOR) 57
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas 55
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics 54
Cardiotoxicity of anti-HER2 drugs in the treatment of metastatic breast cancer: Case report 53
Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients 52
Pembrolizumab-Induced Psoriasis in Metastatic Melanoma: Activity and Safety of Apremilast, a Case Report 51
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 50
Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab 46
Polymorphic variants in NR1I3 and UGT2B7 predict taxane neurotoxicity and have prognostic relevance in breast cancer patients: a case-control study. 45
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up 45
Gut Microbiota Are a Novel Source of Biomarkers for Immunotherapy in Non-Small-Cell Lung Cancer (NSCLC) 42
Economic Evaluation Of A New Non-Antibiotic First-line Treatment Of Recurrent Urinary Tract Infections 42
Modeling UGT2B7 and NR1I3 genes through multilayer network to highlight hidden link with taxane neurotoxicity 41
Personalized medicine in colorectal cancer diagnosis and treatment: a systematic review of health economic evaluations 41
Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis 40
Ramucirumab In Gastric Cancer Treatment: An Economic Evaluation 38
Bioinformatic challenges for pharmacogenomic study: tools for genomic data analysis 37
Real-World Clinical Outcomes of Ribociclib in Combination with a Non-Steroidal Aromatase Inhibitor and a Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal HR+/HER2− Advanced Breast Cancer Patients: An Italian Managed Access Program 36
Prevalence of Non-Erosive Esophageal Phenotypes in children: a European multicenter study 33
Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity 33
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience 29
LNA-i-miR-221 activity in colorectal cancer: A reverse translational investigation 29
Frontline therapy CLL without 17p del/p53 aberrations: systematic review and Bayesian network meta-analysis 28
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma 28
Network meta-analysis of randomized trials in multiple myeloma: efficacy and safety in relapsed/refractory patients. 27
Why Do You Treat pCR Patient With Pertuzumab and Trastuzumab? 26
First-line systemic treatment for hepatocellular carcinoma: A systematic review and network meta-analysis 24
UMG1/CD3ε-bispecific T-cell engager redirects T-cell cytotoxicity against diffuse large B-cell lymphoma 23
Risk-Based Therapeutic Strategies for HER2-Positive Early Breast Cancer: A Consensus Paper 23
The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis 20
Totale 1.501
Categoria #
all - tutte 11.835
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.835


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202122 0 0 0 0 3 3 1 0 5 9 1 0
2021/202245 0 0 1 17 0 2 0 9 4 8 2 2
2022/2023176 24 9 5 8 14 15 4 7 26 28 31 5
2023/2024139 44 10 12 6 7 26 1 1 0 7 13 12
2024/2025495 32 13 11 8 20 78 15 20 42 8 104 144
2025/2026610 74 114 153 188 81 0 0 0 0 0 0 0
Totale 1.501